George Soros Reports New Stake in Arno Therapeutics

George Soros‘ Soros Fund Management has just reported initiating a passive stake Arno Therapeutics Inc (OTCMKTS:ARNID), which contains 2,039,333 million shares. The new position is equal to 9.99% of Arno’s common stock.

SOROS FUND MANAGEMENT

Disclosure: none

Recommended Reading:

Ithan Creek Initiates Exposure in Essent Group

Raging Capital Management Boosts Stake in PLX Technology

Davidson Kempner and 2 Investors Disclose Positions in Quartet Merger Corp